Global Nutrigenomics Market by Application (Obesity, Cardiovascular Diseases, Cancer Research) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Industry Insights
Global nutrigenomics market was valued at USD 252.20 millions in 2017. It is expected to grow at a CAGR 16.48% over the forecast years. The market is expected to grow due to increasing awareness and obesity. Market expansion will also be driven by the growing popularity of customized diets among athletes.
Market growth will be driven by the increasing importance of healthy food in preventive measures against obesity, related diseases, various cardiovascular diseases, malnutrition, and other ailments. Research on cancer based on individual nutrition is on the rise as many scientists highlight that diet regulation can lower your risk of developing it.
In 2017, obesity and cancer research were the most prominent applications segments. They are expected to continue dominance in the future.
Nutrigenomics is a way to bridge the gap between genetics and how they respond to a diet. The development of gluten-free and lactose-free foods can be seen as changes that are made according to specific gene variants.
Many top food manufacturers are now focusing on tailor-made foods to meet a specific gene profile. This includes strengthening the weak immune system or reducing cholesterol. It is still difficult to prove it, however.
Applications Insights
Nutrigenomics is a key component of all biotechnological research. It can be used in many areas, including cancer research, molecular biology analysis, gene therapy, tissue engineering, drug design, biopharmaceutical manufacturing, and vaccine production.
An in-depth study of the nutrigenomics industry reveals that the areas of manufacturing biopharmaceuticals and vaccines are the most lucrative. This dominance can be attributed to the fact that mass culture of animal cells, particularly mammalians is an essential step in the production of biotechnological products.
The use of protein-based biopharmaceuticals has seen a substantial increase due to advances in genetic engineering. The protein expression systems that are derived from mammalian nutritionomics and the creation of high-yielding cell lines are key factors in their production. The biopharmaceutical sector's recently developed application of nutrigenomics is responsible for most revenue and will continue to do so throughout the forecast period.
Regional Insights
In 2017, North America was the market with the highest revenue share. Due to the development and introduction of direct-to-consumer nutrigenomics kits, and the increased intake of specialty food and diet in the region, the regional market will grow further in the future. According to a survey of 9000 people in nine countries, nutrigenomics is now widely recognized. People are willing to use it if there is a legal guarantee that they will not misuse the genetic data.
Asia Pacific is expected to see significant growth due to increased demand for functional foods. Japan is the region's largest consumer of functional food, and this will continue to drive the market in the future.
Nutrigenomics Market Share Insights
Koninklijke DSM N.V., Royal DSM; Danone; GeneSmart; Unilever; Genova Diagnostics; Inc.; Nutrigenomix, Inc.; Metagenics, Inc.; WellGen, Inc.; Cell Logic are some of the major players in the global market. These companies are focused on merging with other research facilities to develop ideal genetic tests. Manufacturers face the biggest hurdle in developing better testing kits and getting approval from regulatory bodies. These changes could help to fuel the market in future.
Report Scope
Attribute |
More Details |
Base year for estimation |
2017 |
Actual estimates/Historical data |
2014 - 2016 |
Forecast period |
2018 - 2025 |
Representation of the market |
From 2018 to 2025, revenue in USD million and CAGR |
Regional scope |
North America, Europe and Asia Pacific, Latin America, Middle East & Africa, and Latin America |
Country coverage |
U.S.A., Canada and Germany. U.K. China, Japan, Brazil and South Africa. |
Report coverage |
Forecast revenue, company share, competitive landscape and growth factors and trends |
15% off customization scope (equivalent of 5 analyst working days). |
We will customize the report to provide you with any additional information that you require. |
The Report Covers Certain Segments
This report forecasts volume and revenue growth at the global, regional and country level. It also provides analysis of industry trends for each sub-segment from 2014-2025. Up Market Research has divided the global nutrigenomics report by application and region.
-
App Outlook (Revenue USD Million, 2014-2025)
-
Obesity
-
Cardiovascular Diseases
-
Cancer Research
-
-
Regional Outlook (Revenue USD Million, 2014-2025)
-
North America
-
The U.S.
-
Canada
-
-
Europe
-
Germany
-
U.K.
-
-
Asia Pacific
-
China
-
Japan
-
-
Latin America
-
Brazil
-
-
Middle East & Africa
-
South Africa
-
-
Up Market Research published a new report titled “Nutrigenomics Market research report which is segmented by Application (Obesity, Cardiovascular Diseases, Cancer Research), By Players/Companies Inc; and Cell Logic Most of these companies are focusing on mergers and collaborations with various research facilities for the development of ideal genetic tests The development of better testing kits and its approval by regulatory bodies is the main hurdle for the manufacturers and these changes can help fuel the market in the future, Inc; WellGen, Koninklijke DSM NV (Royal DSM); BASF SE; Danone; GeneSmart; Unilever; Genova Diagnostics; Inc; Nutrigenomix, Inc; Metagenics”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
Report Attributes | Report Details |
Report Title | Nutrigenomics Market Research Report |
By Application | Obesity, Cardiovascular Diseases, Cancer Research |
By Companies | Inc; and Cell Logic Most of these companies are focusing on mergers and collaborations with various research facilities for the development of ideal genetic tests The development of better testing kits and its approval by regulatory bodies is the main hurdle for the manufacturers and these changes can help fuel the market in the future, Inc; WellGen, Koninklijke DSM NV (Royal DSM); BASF SE; Danone; GeneSmart; Unilever; Genova Diagnostics; Inc; Nutrigenomix, Inc; Metagenics |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 246 |
Number of Tables & Figures | 173 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Nutrigenomics Market Report Segments:
The market is segmented by Application (Obesity, Cardiovascular Diseases, Cancer Research).
Nutrigenomics Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Nutrigenomics Market
Overview of the regional outlook of the Nutrigenomics Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Nutrigenomics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Nutrigenomics Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Obesity
2. Cardiovascular Diseases
3. Cancer Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nutrigenomics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Nutrigenomics Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nutrigenomics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nutrigenomics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nutrigenomics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nutrigenomics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nutrigenomics Market Size & Forecast, 2018-2028
4.5.1 Nutrigenomics Market Size and Y-o-Y Growth
4.5.2 Nutrigenomics Market Absolute $ Opportunity
Chapter 5 Global Nutrigenomics Market Analysis and Forecast by Application
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Application
5.1.2 Basis Point Share (BPS) Analysis by Application
5.1.3 Absolute $ Opportunity Assessment by Application
5.2 Nutrigenomics Market Size Forecast by Application
5.2.1 Obesity
5.2.2 Cardiovascular Diseases
5.2.3 Cancer Research
5.3 Market Attractiveness Analysis by Application
Chapter 6 Global Nutrigenomics Market Analysis and Forecast by Region
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Region
6.1.2 Basis Point Share (BPS) Analysis by Region
6.1.3 Absolute $ Opportunity Assessment by Region
6.2 Nutrigenomics Market Size Forecast by Region
6.2.1 North America
6.2.2 Europe
6.2.3 Asia Pacific
6.2.4 Latin America
6.2.5 Middle East & Africa (MEA)
6.3 Market Attractiveness Analysis by Region
Chapter 7 Coronavirus Disease (COVID-19) Impact
7.1 Introduction
7.2 Current & Future Impact Analysis
7.3 Economic Impact Analysis
7.4 Government Policies
7.5 Investment Scenario
Chapter 8 North America Nutrigenomics Analysis and Forecast
8.1 Introduction
8.2 North America Nutrigenomics Market Size Forecast by Country
8.2.1 U.S.
8.2.2 Canada
8.3 Basis Point Share (BPS) Analysis by Country
8.4 Absolute $ Opportunity Assessment by Country
8.5 Market Attractiveness Analysis by Country
8.6 North America Nutrigenomics Market Size Forecast by Application
8.6.1 Obesity
8.6.2 Cardiovascular Diseases
8.6.3 Cancer Research
8.7 Basis Point Share (BPS) Analysis by Application
8.8 Absolute $ Opportunity Assessment by Application
8.9 Market Attractiveness Analysis by Application
Chapter 9 Europe Nutrigenomics Analysis and Forecast
9.1 Introduction
9.2 Europe Nutrigenomics Market Size Forecast by Country
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 U.K.
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 Europe Nutrigenomics Market Size Forecast by Application
9.6.1 Obesity
9.6.2 Cardiovascular Diseases
9.6.3 Cancer Research
9.7 Basis Point Share (BPS) Analysis by Application
9.8 Absolute $ Opportunity Assessment by Application
9.9 Market Attractiveness Analysis by Application
Chapter 10 Asia Pacific Nutrigenomics Analysis and Forecast
10.1 Introduction
10.2 Asia Pacific Nutrigenomics Market Size Forecast by Country
10.2.1 China
10.2.2 Japan
10.2.3 South Korea
10.2.4 India
10.2.5 Australia
10.2.6 South East Asia (SEA)
10.2.7 Rest of Asia Pacific (APAC)
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Asia Pacific Nutrigenomics Market Size Forecast by Application
10.6.1 Obesity
10.6.2 Cardiovascular Diseases
10.6.3 Cancer Research
10.7 Basis Point Share (BPS) Analysis by Application
10.8 Absolute $ Opportunity Assessment by Application
10.9 Market Attractiveness Analysis by Application
Chapter 11 Latin America Nutrigenomics Analysis and Forecast
11.1 Introduction
11.2 Latin America Nutrigenomics Market Size Forecast by Country
11.2.1 Brazil
11.2.2 Mexico
11.2.3 Rest of Latin America (LATAM)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Latin America Nutrigenomics Market Size Forecast by Application
11.6.1 Obesity
11.6.2 Cardiovascular Diseases
11.6.3 Cancer Research
11.7 Basis Point Share (BPS) Analysis by Application
11.8 Absolute $ Opportunity Assessment by Application
11.9 Market Attractiveness Analysis by Application
Chapter 12 Middle East & Africa (MEA) Nutrigenomics Analysis and Forecast
12.1 Introduction
12.2 Middle East & Africa (MEA) Nutrigenomics Market Size Forecast by Country
12.2.1 Saudi Arabia
12.2.2 South Africa
12.2.3 UAE
12.2.4 Rest of Middle East & Africa (MEA)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Middle East & Africa (MEA) Nutrigenomics Market Size Forecast by Application
12.6.1 Obesity
12.6.2 Cardiovascular Diseases
12.6.3 Cancer Research
12.7 Basis Point Share (BPS) Analysis by Application
12.8 Absolute $ Opportunity Assessment by Application
12.9 Market Attractiveness Analysis by Application
Chapter 13 Competition Landscape
13.1 Nutrigenomics Market: Competitive Dashboard
13.2 Global Nutrigenomics Market: Market Share Analysis, 2019
13.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
13.3.1 Inc; and Cell Logic Most of these companies are focusing on mergers and collaborations with various research facilities for the development of ideal genetic tests The development of better testing kits and its approval by regulatory bodies is the main hurdle for the manufacturers and these changes can help fuel the market in the future
13.3.2 Inc; WellGen
13.3.3 Koninklijke DSM NV (Royal DSM); BASF SE; Danone; GeneSmart; Unilever; Genova Diagnostics; Inc; Nutrigenomix
13.3.4 Inc; Metagenics